[AR101: therapy for peanut allergy finally in view?]
1UMC Utrecht, afd. Immunologie en afd. Dermatologie/Allergologie.
Insights
Oral immunotherapy with AR101 shows promise for treating peanut allergy, a growing global health concern. However, further research is needed due to side effects and uncertain long-term tolerance.
Area of Science:
- Allergy and Immunology
- Clinical Therapeutics
- Pediatric Medicine
Background:
- Peanut allergy incidence is rising globally.
- Spontaneous tolerance is rare in affected children.
- Current treatments for peanut allergy lack proven efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of AR101 oral immunotherapy for peanut allergy.
- To assess the potential of AR101 as a therapeutic option for peanut allergy.
Main Methods:
- The study involved the PALISADE trial, a clinical investigation of AR101.
- Oral immunotherapy was administered to participants with peanut allergy.
Main Results:
- Promising results were reported from the PALISADE trial.
- AR101 demonstrated potential in managing peanut allergy.
Conclusions:
- AR101 shows promise but has notable side effects.
- Long-term tolerance persistence after AR101 therapy cessation requires further investigation.
- AR101 is not yet ready for standard peanut allergy treatment.
Abstract:
AR101: therapy for peanut allergy finally in view? Worldwide, the incidence of peanut allergy is increasing. Spontaneous tolerance only occurs in a small percentage of children who are allergic to peanuts. To date, no treatment for this potentially life-threatening condition has been proven effective. However, the recently published results of the PALISADE trial on oral immunotherapy with AR101 are promising. As AR101 has many side effects, and as it is unclear if tolerance persists after therapy is stopped, there is still a long way to go before AR101 can be added to the standard treatment for peanut allergy.
Related Concept Videos
01:29Econometric Views (EViews)
01:27Cranial Bones: Lateral View
The temporal bone forms the lower lateral side of the skull. The temporal bone is subdivided into several regions. The flattened upper portion is the squamous portion of the temporal bone. Below this area and projecting anteriorly is the zygomatic process of the temporal bone, which forms the posterior portion of the zygomatic arch. Posteriorly is the mastoid portion of the temporal bone. Projecting...
01:24Revisionist Views of Adolescent and Adult Cognition
00:59Gene Therapy
01:14Cranial Bones: Superior and Posterior View
The frontal bone is the single bone that forms the forehead. At its anterior midline, between the eyebrows, there is a slight depression called the glabella. The frontal bone also forms the supraorbital margin of the orbit. Near the middle of this margin is the supraorbital foramen, the opening that provides passage for a sensory nerve to the forehead. The frontal bone is thickened just above each supraorbital margin,...
01:26Group Therapy